NASDAQ:BDRX

Biodexa Pharmaceuticals American Depositary Shs Stock Forecast

etoro logo Buy BDRX
*Your capital is at risk
$2.13
+0 (+0%)
At Close: Jul 17, 2026
AI Analysis AI Analysis of BDRX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BDRX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Biodexa Pharmaceuticals Plc American stock upgraded from Strong Sell Candidate to Sell Candidate after Friday trading session
(Updated on Jul 17, 2026)

Sell candidate since Jun 10, 2026 Loss -29.24%

No changes to the price of Biodexa Pharmaceuticals Plc American stock on the last trading day (Friday, 17th Jul 2026). During the last trading day the stock fluctuated 6.94% from a day low at $2.02 to a day high of $2.16. The price has fallen in 9 of the last 10 days and is down by -27.55% for this period.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.11 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -28.40% during the next 3 months and, with a 90% probability hold a price between $1.51 and $2.65 at the end of this 3-month period.

BDRX Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, July 16, 2026, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Volume gained on the last day while the price remained unchanged. This is not a classical divergence, but the stock should be watched more closely at it may be a "turning point". The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Biodexa Pharmaceuticals Plc American stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.31 and $2.90. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Biodexa Pharmaceuticals Plc American stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.140 between high and low, or 6.94%. For the last week, the stock has had daily average volatility of 8.93%.

Biodexa Pharmaceuticals Plc American is oversold on RSI14 (14). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BDRX) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Biodexa Pharmaceuticals Plc American Depositary Shs to open at $2.10, and during the day (based on 14 day Average True Range), to move between $2.01 and $2.25, which gives a possible trading interval of +/-$0.231 (+/-11.49%) up or down from last closing price. If Biodexa Pharmaceuticals Plc American Depositary Shs takes out the full calculated possible swing range there will be an estimated 11.49% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $2.31, some $0.180 (8.45%) from the current price of $2.13, our system finds the risk reward not very attractive.

Is Biodexa Pharmaceuticals Plc American Depositary Shs stock A Buy?

Biodexa Pharmaceuticals Plc American holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.837 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 20, 2026 - $2.10 ( 1.25%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BDRX Performance

Trading levels for BDRX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 2.24 5.33%
R2 2.19 2.81%
R1 2.16 1.26%
Price 2.13
S1 2.05 -3.76%
S2 2.02 -5.32%
S3 1.96 -7.83%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.66 24.88%
R2 2.59 21.60%
R1 2.31 8.45%
Price 2.13
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Biodexa Pharmaceuticals Plc American Depositary Shs Stock and on which exchange is it traded?
The symbol for Biodexa Pharmaceuticals Plc American Depositary Shs is BDRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Biodexa Pharmaceuticals Plc American Depositary Shs Stock?
Biodexa Pharmaceuticals Plc American holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Biodexa Pharmaceuticals Plc American Depositary Shs Stock?
Biodexa Pharmaceuticals Plc American Depositary Shs Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Biodexa Pharmaceuticals Plc American Depositary Shs Stock.

What's the current price of Biodexa Pharmaceuticals Plc American Depositary Shs Stock?
As of the end of day on the Jul 17, 2026, the price of an Biodexa Pharmaceuticals Plc American Depositary Shs (BDRX) share was $2.13.

What is the 52-week high and low for Biodexa Pharmaceuticals Plc American Depositary Shs Stock?
The 52-week high for Biodexa Pharmaceuticals Plc American Depositary Shs Stock is $59.40 and the 52-week low is $2.02.

What is the market capitalization of Biodexa Pharmaceuticals Plc American Depositary Shs Stock?
As of the Jul 17, 2026, the market capitalization of Biodexa Pharmaceuticals Plc American Depositary Shs is 1.589M.

When is the next earnings date for Biodexa Pharmaceuticals Plc American Depositary Shs?
The upcoming earnings date for Biodexa Pharmaceuticals Plc American Depositary Shs is Sep 11, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
0.578% Jul 13
SRPT
$17.02
1.18% Jun 29
JLL
$299.78
10.30% Jun 24
NMRK
$15.02
3.86% Jun 24
CAG
$13.43
6.29% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE